Outcomes, Access, and Cost Issues Involving PCSK9 Inhibitors to Lower LDL-Cholesterol

Overview of attention for article published in Drugs, February 2018

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 1,830 followers.

RT @RevistaMFSamfyc: Aspectos de resultados, acceso y costes respecto a los inhibidores de PCSK9 para bajar el colesterol LDL https://t.co/…

Aspectos de resultados, acceso y costes respecto a los inhibidores de PCSK9 para bajar el colesterol LDL https://t.co/57dWivUhwi PMID 29396831

Latest article on PCSK9 inhibitors from Dr Thonas Whayne. #Cardiology #cholesterol @UK_HealthCare https://t.co/dBkQr2XgYD